Annual Drug Patent Expirations for NALOXONE+HYDROCHLORIDE+%28AUTOINJECTOR%29
Naloxone Hydrochloride (autoinjector) is a drug marketed by Kaleo Inc and is included in one NDA. It is available from one supplier. There are nineteen patents protecting this drug.
Drug patent litigation for NALOXONE HYDROCHLORIDE (AUTOINJECTOR).
This drug has one hundred and thirty-eight patent family members in fifteen countries.
The generic ingredient in NALOXONE HYDROCHLORIDE (AUTOINJECTOR) is naloxone hydrochloride. One supplier is listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com